Skip to main content

EDITORIAL article

Front. Oncol., 21 November 2023
Sec. Cancer Imaging and Image-directed Interventions
This article is part of the Research Topic Case Reports in Cancer Imaging and Image-directed Interventions : 2022 View all 10 articles

Editorial: Case reports in cancer imaging and image-directed interventions : 2022

  • Dipartimento di Scienze Biomediche, Odontoiatriche, Morfologiche e Funzionali per Immagini, Università degli Studi di Messina, Messina, Italy

Today, imaging is an indispensable tool for cancer detection and characterization.

Both morphological and functional imaging, independently but, above all, in an integrated manner, allow early diagnosis of numerous neoplastic pathologies.

In recent years, technology has enabled notable growth in diagnostic imaging thanks, for example, to the possibility of acquiring very thin slices, new MRI sequences, or increasingly elaborate and high-performance postprocessing, which is extremely useful in some pathologies or in certain anatomical districts (1, 2).

Nowadays, besides the diagnostic role, there is the possibility of using imaging as a guide to treat some of these pathologies in a less invasive way.

Interventional radiology and, specifically, interventional oncology have by now a consolidated role in the therapeutic process of many neoplasms, assuming the role of the fourth pillar of anti-tumor therapy alongside surgery, radiotherapy, and medical oncology (3-7).

In this Frontiers Research Topic, the authors were expected to provide case reports that highlight unique cases of patients that present with an unexpected diagnosis, treatment outcome, or clinical course (8).

Several contributions focused on the diagnosis of rare tumors or rare manifestations of more common tumors (Li et al.; Wang et al.; Hu et al.; Fischerova et al.).

Li et al. presented a case of osteofibrous dysplasia-like adamantinoma, a rare bone tumor (0.4% of all primary bone tumors) recently proposed in the new WHO classification of bone tumors of 2020 and classified as an intermediate locally aggressive tumor. Imaging can demonstrate the lesion and could provide support for differential diagnosis, although a multidisciplinary evaluation is required to reach the diagnosis.

Another very rare tumor that could involve bone was reported by (Wang et al.).

Proliferating trichilemmal tumors originate from the outer root sheath of hair follicles generally located in the head and neck region. Other localizations are uncommon in this condition.18 F-FDG-PET could be very useful in identifying both the tumor and any metastatic lymph nodes.

Starting from the presentation of a case, Hu et al. provide a comprehensive literature review of primary intracranial Ewing sarcomas/primitive neuroectodermal tumors, an extremely rare condition with poor prognosis. Unfortunately, only in few cases, they manifest themselves with relatively specific features at imaging; therefore, final diagnosis mainly depends on pathology and immunohistochemistry.

Fischerova et al. reported a rare case of retroperitoneal nodal endometroid carcinoma diagnosed through US-guided biopsy without any macroscopic relevance in the abdomen and pelvis. Immunohistochemical and genetic analysis helped to detect an unknown Lynch syndrome, a congenital condition that could lead to carcinogenesis.

Another aspect of the present Research Topic has been reported by Zhang et al., Li et al., and (Zhang et al.). All of them focused their articles on the usefulness of the uncommon application of specific imaging techniques in certain clinical conditions.

Zhang et al. proposed the use of multimodality US in the detection and characterization of metastasis of rare subtype of renal cell carcinoma (fumarate hydratase-deficient RCC). Application of grayscale, color Doppler, power Doppler, and contrast-enhanced US allow to detect metastasis; characterization could be feasible by ultrasonographic findings accompanied by US-guided biopsy.

In their article, Li et al. enhanced the strength of 68Ga-conjugated fibroblast-activation protein inhibitor (FAPI) PET/CT versus 18F-FDG in the identification process of intra-abdominal breast cancer metastasis thanks to a better tumor-to-background ratio and lack of interference by non-specific gastrointestinal physiological uptake.

Zhang et al. described contrast-enhanced ultrasound (CEUS) findings of intraperitoneal nodal large B-cell lymphoma. Usually, CT and PET/CT are employed for diagnosis and staging, but in recent years, many studies have focused on alternative imaging methods. CEUS can demonstrate the changes of vascularity of lymph nodes and, at the same time, allow to perform US-guided biopsy to confirm diagnosis.

This Research Topic is completed by two Case Reports involving hepatic diseases.

Shao et al. described a unique imaging pattern of a metastatic neuroendocrine neoplasm characterized by a steatosis area surrounding the hepatic localization. In this article, US findings were reported, and the support of CEUS in differential diagnosis was enhanced.

Congenital portosystemic shunts in children were the focus of (Zhang et al.). The prevalence of these vascular anomalies is 1 in 30000-50000 neonates and may present with various symptoms.

Imaging is essential in diagnosis with US as the first modality of choice in early identification, allowing the prompt management of potentially life-threatening manifestations. Moreover, imaging has a strong role in treatment thanks to the efficacy of endovascular techniques in occluding the shunts.

In conclusion, the contributions presented in this Research Topic have enriched our knowledge of cancer imaging, shedding light on rare neoplastic conditions, their imaging findings, and the implications for the choice of appropriate treatment, often performed under imaging guidance.

All of these studies provide suggestions for further investigation in this field.

Author contributions

AB: Writing – original draft, Writing – review & editing.

Conflict of interest

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: interventional radiology (IR), interventional oncology (IO), cancer imaging, image- guided biopsies, image-guided radiotherapy

Citation: Bottari A (2023) Editorial: Case reports in cancer imaging and image-directed interventions : 2022. Front. Oncol. 13:1310454. doi: 10.3389/fonc.2023.1310454

Received: 09 October 2023; Accepted: 10 November 2023;
Published: 21 November 2023.

Edited and Reviewed by:

Zaver Bhujwalla, Johns Hopkins University, United States

Copyright © 2023 Bottari. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Antonio Bottari, bottaria@unime.it

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.